Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Mawdsleys agrees distribution deals with Tillomed Laboratories and Strides Pharma

Mawdsleys agrees distribution deals with Tillomed Laboratories and Strides Pharma

27th September 2017

Mawdsleys has announced a pair of new distribution deals with Tillomed Laboratories and Strides Pharma.

The company will be assisting Tillomed Laboratories in bringing its range of injectable products to market, providing Commercial Medicines Unit (CMU)-contracted products to English hospitals and products with special prices for Scotland, Wales and Northern Ireland.

These include carmustine for injection, cidofovir solution and injections, and melphalan for injection.

A Tillomed Laboratories statement said: "We are pleased to be working alongside Mawdsleys, who are acknowledged as a market leader in hospital distribution, and we look forward to strengthening our partnership over the forthcoming years with new launches."

Meanwhile, the Strides Pharma UK deal will see Mawdsleys providing products to English hospitals as part of the CMU contract, including prednisolone and azathioprine tablets.

With both of these contracts, the firm will be augmenting its services by offering 22-day average stock holding, live stock levels, prices and invoices, and online ordering capabilities.

With over 20 years of experience within the consumer market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current consumer roles we have available, you can search for the latest job roles, register your details, or contact the team today.

We currently have 8 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.